CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
Introduction: Genetic polymorphisms of CYP2C9 among different populations in different geographical regions could be dif ferent . CYP2C9 has been reported to be the enzyme responsible for the metabolism of many drugs, including warfarin and other drugs with a narrow therapeutic index. Realisin...
Saved in:
Main Authors: | Ngow, Harris Abdullah, Wan Khairina, Wan Mohd Nowalid, Teh , Lay Kek, Lee, Wee Leng, Harun, Roslan, Ismail, Rusli, Salleh, Mohd Zaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Singapore Medical Association
2009
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5194/1/CYP2C9_Poly_in_SMJ_2009.pdf http://irep.iium.edu.my/5194/ http://smj.sma.org.sg/5005/5005a6.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
by: Salleh, Mohd Zaki, et al.
Published: (2009) -
Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008) -
Genetic polymorphism of CYP2C9 in patients on warfarin therapy and the clinical relevance / Teh Lay Kek ... [et al.]
by: Teh, Lay Kek, et al.
Published: (2007) -
VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010) -
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011)